You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cetuximab

Showing 26 - 50 of 1,156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jul 12, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, China
    Fudan University
Jan 4, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Shanghai (MRG003, Cetuximab injection, Methotrexate Injection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Feb 21, 2023

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma Trial in Groningen

Not yet recruiting
  • Barrett's Esophagus Without Dysplasia
  • +2 more
  • Groningen, Netherlands
    University Medical Center Groningen
Feb 24, 2023

Chordoma, Metastatic Chordoma, Unresectable Chordoma Trial in Houston (Cetuximab, Questionnaire Administration)

Recruiting
  • Chordoma
  • +2 more
  • Cetuximab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Jun 1, 2022

Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

Recruiting
  • Head and Neck Squamous Cell Cancer
  • Toripalimab Injection
  • Cetuximab Solution for infusion
  • Shanghai, China
    Shanghai East Hospital
Dec 15, 2022

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

Recruiting
  • Squamous Cell Cancers of the Head and Neck
  • New Haven, Connecticut
    Yale Cancer Center
Jan 10, 2023

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • (no location specified)
Aug 18, 2022

Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)

Active, not recruiting
  • Recurrent Head and Neck Cancer
  • +3 more
  • Cincinnati, Ohio
    UC Health
Oct 3, 2022

Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)

Recruiting
  • Neoadjuvant Treatment
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Apr 15, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)

Active, not recruiting
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • PD 0332991
  • Atlanta, Georgia
  • +4 more
Nov 1, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022

A Small-sample, Real-world Study of Sintilimab Plus

Recruiting
  • Colorectal Cancer
  • Sintilimab ，bevcizumab/cetuximab，XELOX
  • Xi'an, Shanxi, China
    Yang Jianjun
Sep 14, 2022